88IV - PR Newswire Asia's news


Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , March 19, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study CHENGDU, China , March 18, 2026 /PRNewswire/ -- The 2026 European Lung Cancer Congress (ELCC) will be held in Copenhagen, Denmark, from March 25 to 28, 2026 (local time). At this congress, the final ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Alphamab Oncology Appoints Mr. Fei Wang as Chief Financial Officer SUZHOU, China , March 18, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced the appointment of Mr. Fei Wang as Chief Financial Officer (CFO). Mr. Wang will be responsible for ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support Largest-ever grant from RIGHT Foundation to accelerate Phase 1b clinical trial of RSV preventive antibody Technology licensed from Gates MRI; early studies confirm suppression of RSV infection ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new species across thousands of sites globally. By partnering with Anthropic, ... 2026-03-18T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine Marketing Authorization in Vietnam; Joins Forces with Substipharm Biologics to Expand Southeast Asian Market TAIPEI and GENEVA , March 18, 2026 /PRNewswire/ -- Medigen Vaccine Biologics Corp. (MVC) and Substipharm Biologics announced on March 17 that ENVACGEN®, an Enterovirus 71 (EV-A71) vaccine, ... 2026-03-18T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited SHANGHAI , March 18, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs SHANGHAI and HONG KONG , March 18, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy TAIPEI and SAN DIEGO , March 18, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innorna Announces FDA Clearance of IND for IN026, Advancing mRNA-based Therapies into Chronic Metabolic Diseases IN026 is a potential first-in-class mRNA therapy for refractory gout, marking the emergence of a new category of mRNA medicines enabled by Innorna's proprietary mRNA–LNP platform. ... 2026-03-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology